skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

ファーマインテリジェンスが選ばれる理由

business Intelligence sales forecasts pharma intelligence

世界有数の医薬品業界情報プロバイダー

日々激しさを増す医薬品・医療機器市場において、質の高い医薬品業界ニュースやマーケット分析をグローバルで提供する世界有数の情報プロバイダーです。

news and insight analyst page expertise in all areas pharma intelligence

リアルタイムのニュース配信サービス

世界中のアナリストがリアルタイムの医薬品業界ニュースを毎日配信します。事実の報道だけでなく、グローバルな視点で独自の分析と見解をご提供します。

data and analysis indepth company profiles pharma intelligence

確固たるデータに基づいた分析

当社が提供する分析は、175か国、4万2千社による24万8千件の臨床試験、および、1400種の疾病に対する6万5千の医薬品データに基づいています。

consultancies pharma intelligence

オーダーメードのプロジェクトもご提供

顧客企業ごとのビジネスニーズに対応する実用的なコンサルテーションサービスをご提供します。投資利益率向上のためにお客様の組織を内側から支えます。

ask the analyst pharma intelligence

世界規模の視点が強み医薬専門のアナリスト

300名超の専属アナリストと65名のジャーナリストが、世界中の製薬業界情報を網羅します。

dedicated account manager pharma intelligence

3000社以上のお客様と取引実績

当社は世界の製薬会社トップ50社および医薬品開発業務受託機関(CRO)の上位10社を含む3000社以上のお客様にサービスをご提供してきました。

 

gold standard service product developments pharma intelligence

顧客第一のカスタマーサポート

ニュース配信サービスから調査・分析業務、コンサル等のカスタマイズサービスまで。カスタマーサポートがお客様のお問合せに一つ一つ丁寧に対応します。

solution to suity our need epidemiology pharma intelligence

一人ひとりのお客様に最適なソリューション

分析レポート単体の購入から法人単位の購読契約やコンサル案件まで。各お客様のニーズにしっかり向き合います。

ファーマインテリジェンスが提供するサービスブランド

Biomedtracker
DMHC
In Vivo
Meddevicetracker
Medtech-Insight
Medtrack
Pharma consulting
Pharmapremia
Pharmaprojects
Pink Sheet
RxScorecard
Scrip
Sitetrove
Trialtrove

メールサービスの最新記事

  • Asco Essentials Webinar 2018 Recording

    25 May 2018

    The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform

    Clinical trials

  • Scrip:世界の医薬品産業ニュースサービス

    New Chugai CEO Lays Course As He Takes Reins

    25 May 2018

    Chugai's new CEO Tatsuro Kosaka took up his position in March and is charged with taking the major Japanese company through the next stage of development as key products reach the global market and others begin to face biosimilar competition. In this first part of a two-part exclusive interview, he outlines the firm's vision, approach to R&D and how the strategic alliance with Roche is playing out.

    Topic Business strategies Research

  • Scrip:世界の医薬品産業ニュースサービス

    Remember When Provenge's Price Was Bold? Every New Cancer Drug In 2017 Cost $100,000 Or More

    25 May 2018

    The price of new oncology brands doubled in the US from 2013 to 2017, bringing the median annual price to more than $160,000 last year, up from $79,000 in 2013, according to a new IQVIA report. Spending on cancer drugs in the US has doubled since 2012, reaching nearly $50bn in 2017.

    Topic Cancer

  • Webinar recording: Partnering shared expertise and technology to optimize study planning

    Loni Branon 24 May 2018

    The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform.

    Clinical trials

  • Medtech Insight:世界の医療機器に特化したニュース配信

    Companion Diagnostics Webinar Recording

    By Derrick Gingery 24 May 2018

    Companion diagnostics are poised to be a huge growth area worldwide, with a CAGR of 20.1% over the next 5 years, making it a $6B industry by 2022. These often in-vitro medical devices provide essential information for the efficacy of a corresponding drug or biological product, and are also used for pre-determining the efficacy of treatment. Their growth is being propelled in most countries by a number of favorable factors.

    Topic Medtech

  • Pharmaprojects

    Pharma RD Review Webinar

    By Ian Lloyd 24 May 2018

    Keep in tune with the current landscape for pharma R&D with a free, information-packed webinar recording from Informa Pharma Intelligence. In the Global Pharma R&D Review webinar, our experts hit all the right notes as they used a music theme to explore key issues affecting R&D today, and offer a glimpse of what the rest of 2018 may look like.

  • Scrip:世界の医薬品産業ニュースサービス

    Pfizer's Three-Pronged Oncology Strategy Includes Expanding Ibrance, Xtandi, Developing Blockbuster Combos

    23 May 2018

    Xtandi use in early prostate cancer, lorlatinib as second-line treatment for non-small cell lung cancer and dacomitinib for first-line NSCLC have upcoming user fee dates.

    Topic Cancer

  • Scrip:世界の医薬品産業ニュースサービス

    Missing In Action: China’s Best Shot In Ebola Vaccine Race

    23 May 2018

    As the Congo grapples with the latest outbreak of Ebola, China has approved its first domestically developed vaccine in record time, hailing it a national innovation champion. But as the World Health Organization starts vaccinations in Africa, can China make the cut and compete with global players including Merck & Co?

    Topic Vaccines

  • Medtech Insight

    Despite Only Two Parallel Review Success Stories, CMS Touts Better Coordination

    22 May 2018

    While only two devices have received approval and a national coverage determination through US FDA/CMS' parallel review program, a top CMS official says industry needs to look beyond just the numbers. Instead, she says the parallel review program is part of a sea-change that has allowed for better communication between CMS, FDA and sponsors.

    Topic FDA

  • Pink Sheet:世界の薬事規制と承認審査に関するニュース

    DTC And The Art Of Selling An Establishment Pricing Plan To A Populist President

    22 May 2018

    The most surprising proposal coming out the Rose Garden drug pricing event was a call for disclosure of prices in DTC ads. As a policy idea, it may be a dud – but that doesn’t mean it isn’t a critical element of the plan.

    Topic Drug review Drug approval

  • Pink Sheet:世界の薬事規制と承認審査に関するニュース

    EMA Tackles Tough Job Of Filling UK Void In Working Parties

    By Neena ​ Brizmohun 22 May 2018

    The European Medicines Agency has started the difficult task of finding replacements for the UK chairs and members of its numerous working parties and groups who are having to vacate their position because of Brexit.

    Topic Brexit

  • Medtech Insight

    HRS 2018 Wrap-Up: Tendril Lead Failures; Metaanalysis of Contact-Force Catheter; LuxCath's OmniView; More Micra Results

    By Reed Miller 22 May 2018

    The 2018 Heart Rhythm Society scientific sessions in Boston covered a variety of presentations of new electrophysiology clinical data, including a report on the failure of St. Jude's Tendril leads, a meta-analysis of contact-force catheters for atrial-fibrillation ablation, and new data on Medtronic's Micra leadless pacemaker.

  • Scrip:世界の医薬品産業ニュースサービス

    Pharma Backs UK Parliament Report As 'No Deal Brexit' Fears Grow

    18 May 2018

    The pharmaceutical sector has given its backing to a report from MPs which warns that a no-deal Brexit will have a hugely damaging effect on the industry in the country, turning it into "a second-tier state for new and innovative medicines."

    Topic Brexit Business strategies

  • Scrip:世界の医薬品産業ニュースサービス

    Immuno Oncology: What To Watch At ASCO 2018

    18 May 2018

    Cancer immunotherapy is once again set to dominate the upcoming American Society of Clinical Oncology annual meeting, with a continuing showdown for PD-1 inhibitors in lung cancer, a CAR-T battle, and disappointments for new IO classes.

    Topic Cancer

  • Pink Sheet:世界の薬事規制と承認審査に関するニュース

    CAR-T Therapy In Medicare: National Coverage Policy Could Come In 2019

    18 May 2018

    Medicare begins analysis process for CAR-T cancer therapies in response to a request from United Healthcare for a national coverage policy.

    Topic Cancer cell-and-gene-therapy

関連する製品

trial trove pharma intelligence

Trialtrove

Key benefits:

  • 専門家による情報精査
  • 世界中の臨床試験情報を網羅
  • 標準治療に関する情報
pdpimage

Datamonitor Healthcare

Key benefits:

  • 市場機会を見極める
  • アンメットニーズを特定
  • データドリブンの意思決定
scrip pharma intelligence

Scrip:世界の医薬品産業ニュースサービス

Key benefits:

  • Scripジャーナリストチーム
  • Go beyond the news
  • Hear from news makers

最新のイベント情報

23 Sep 2018

USA

Awards

Medtech Insight Awards 2018 in Partnership with The MedTech Conference

09 Oct 2018

Spain

Awards

Global Generics & Biosimilars Awards 2018

28 Nov 2018

Awards

Scrip Awards 2018

Keep up to date